Tag Archives: Marcelo Muñoz

Peptide-based hydrogels for faster healing from research team at the University of Ottawa

Leave a reply

While this research team was heavily dominated by researchers from the University of Ottawa, there were two members associated with the University of Talca (Universidad de Talca; located in Chile), two members associated with the University of Montreal (Université de Montréal), and one member with McGill University (located in Montréal).

Now for these special hydrogels, from a May 13, 2024 University of Ottawa news release (also on EurekAlert) by David McFadden, Note: Links have been removed,

Combining biomedical finesse and nature-inspired engineering, a uOttawa-led team of scientists have created a jelly-like material that shows great potential for on-the-spot repair to a remarkable range of damaged organs and tissues in the human body.

Cutting-edge research co-led by uOttawa Faculty of Medicine  Associate Professor Dr. Emilio I. Alarcón could eventually impact millions of lives with peptide-based hydrogels that will close skin wounds, deliver therapeutics to damaged heart muscle, as well as reshape and heal injured corneas.

“We are using peptides to fabricate therapeutic solutions. The team is drawing inspiration from nature to develop simple solutions for wound closure and tissue repair,” says Dr. Alarcón, a scientist and director at the BioEngineering and Therapeutic Solutions (BEaTS) group at the University of Ottawa Heart Institutek whose innovative research work is focused on developing new materials with capabilities for tissue regeneration.

Peptides are molecules in living organisms and hydrogels are a water-based material with a gelatinous texture that have proven useful in therapeutics.

The approach used in the study –  just published in Advanced Functional Materials and co-led by Dr. Erik Suuronen & Dr. Marc Ruel – is unique. Most hydrogels explored in tissue engineering are animal-derived and protein-based materials, but the biomaterial created by the collaborative team is supercharged by engineered peptides. This makes it more clinically translatable.

Dr. Ruel, a full professor in the uOttawa Faculty of Medicine’s Department of Cellular and Molecular Medicine and the endowed chair of research in the Division of Cardiac Surgery at the University of Ottawa Heart Institute, says the study’s insights could be a game changer.

“Despite millennia of evolution, the human response to wound healing still remains imperfect,” Dr. Ruel says. “We see maladapted scarring in everything from skin incisions to eye injuries, to heart repair after a myocardial infarction. Drs. Alarcón, Suuronen, and the rest of our team have focused on this problem for almost two decades. The publication by Dr. Alarcón in Advanced Functional Materials reveals a novel way to make wound healing, organ healing, and even basic scarring after surgery much more therapeutically modulatable and, therefore, optimizable for human health.”

Indeed, the ability to modulate the peptide-based biomaterial is key. The uOttawa-led team’s hydrogels are designed to be customizable, making the durable material adaptable for use in a surprising range of tissues. Essentially, the two-component recipe could be adjusted to ramp up adhesivity or dial down other components depending on the part of the body needing repair.

“We were in fact very surprised by the range of applications our materials can achieve,” says Dr. Alarcón. “Our technology offers an integrated solution that is customizable depending on the targeted tissue.”

Dr. Alarcón says that not only does the study’s data suggest that the therapeutic action of the biomimetic hydrogels are highly effective, but its application is far simpler and cost-effective than other regenerative approaches.

The materials are engineered in a low-cost and scalable manner – hugely important qualities for any number of major biomedical applications. The team also devised a rapid-screening system that allowed them to significantly slash the design costs and testing timespans.

“This significant reduction in cost and time not only makes our material more economically viable but also accelerates its potential for clinical use,” Dr. Alarcón says.

What are next steps for the talent-rich research team? They will conduct large animal tests in preparation for tests in human subjects. So far, heart and skin tests were conducted with rodents, and the cornea work was done ex vivo.

Part of the work for this study was funded by the uOttawa Faculty of Medicine’s  “Path to Patenting & Pre-Commercialization” (3P),  an innovation-focused approach to provide our community’s top-flight researchers with the assistance needed to bring their most promising breakthroughs to the wider world.

Here’s a link to and a citation for the paper,

Multipurpose On-the-Spot Peptide-Based Hydrogels for Skin, Cornea, and Heart Repair by Alex Ross, Xixi Guo, German A. Mercado Salazar, Sergio David Garcia Schejtman, Jinane El-Hage, Maxime Comtois-Bona, Aidan Macadam, Irene Guzman-Soto, Hiroki Takaya, Kevin Hu, Bryan Liu, Ryan Tu, Bilal Siddiqi, Erica Anderson, Marcelo Muñoz, Patricio Briones-Rebolledo, Tianqin Ning, May Griffith, Benjamin Rotsein, Horacio Poblete, Jianyu Li, Marc Ruel, Erik J. Suuronen, Emilio I. Alarcon. Advanced Functional Materials DOI: https://doi.org/10.1002/adfm.202402564 First published: 23 April 2024

This paper is open access.

Maybe spray-on technology can be used for heart repair?

Leave a reply
Courtesy: University of Ottawa

That is a pretty stunning image and this March 15, 2022 news item on phys.org provides an explanation of what you see (Note: A link has been removed),

Could a spritz of super-tiny particles of gold and peptides on a damaged heart potentially provide minimally invasive, on-the-spot repair?

Cutting-edge research led by University of Ottawa Faculty of Medicine Associate Professors Dr. Emilio Alarcon and Dr. Erik Suuronen suggests a spray-on technology using customized nanoparticles of one of the world’s most precious metals offers tremendous therapeutic potential and could eventually help save many lives. Cardiovascular diseases are the leading cause of death globally, claiming roughly 18 million lives each year.

In a paper recently published online in ACS Nano, a peer-reviewed journal that highlighted the new research on its supplementary cover, Dr. Alarcon and his team of fellow investigators suggest that this approach might one day be used in conjunction with coronary artery bypass surgeries. That’s the most common type of heart surgery.

A March 15, 2021 University of Ottawa news release (also on EurekAlert) by David McFadden, which originated the news item, describes the research in more detail (Note: A link has been removed),

The therapy tested by the researchers – which was sprayed on the hearts of lab mice – used very low concentrations of peptide-modified particles of gold created in the laboratory. From the nozzle of a miniaturized spraying apparatus, the material can be evenly painted on the surface of a heart within a few seconds.

Gold nanoparticles have been shown to have some unusual properties and are highly chemically reactive. For years, researchers have been employing gold nanoparticles – so tiny they are undetectable by the human eye – in such a wide range of technologies that it’s become an area of intense research interest.

In this case, the custom-made nanogold modified with peptides—a short chain of amino acids —was sprayed on the hearts of lab mice. The research found that the spray-on therapy not only resulted in an increase in cardiac function and heart electrical conductivity but that there was no off-target organ infiltration by the tiny gold particles.

“That’s the beauty of this approach. You spray, then you wait a couple of weeks, and the animals are doing just fine compared to the controls,” says Dr. Alarcon, who is part of the Faculty of Medicine’s Department of Biochemistry, Microbiology and Immunology and also Director of the Bio-nanomaterials Chemistry and Engineering Laboratory at the University of the Ottawa Heart Institute.

Dr. Alarcon says that not only does the data suggest that the therapeutic action of the spray-on nanotherapeutic is highly effective, but its application is far simpler than other regenerative approaches for treating an infarcted heart.

At first, the observed improvement of cardiac function and electrical signal propagation in the hearts of tested mice was hard for the team to believe. But repeated experiments delivered the same positive results, according to Dr. Alarcon, who is part of the Faculty of Medicine’s Department of Biochemistry, Microbiology and Immunology and Director of the Bio-nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute.

To validate the exciting findings in mice, the team is now seeking to adapt this technology to minimally invasive procedures that will expedite testing in large animal models, such as rabbits and pigs.

Dr. Alarcon praised the research culture at uOttawa and the Heart Institute, saying that the freedom to explore is paramount. “When you have an environment where you are allowed to make mistakes and criticize, that really drives discoveries,” he says.

The team involved in the paper includes researchers from uOttawa and the University of Talca in Chile. Part of the work was funded by the Canadian government’s New Frontiers in Research Fund, which was launched in 2018 and supports transformative high risk/high reward research led by Canadian researchers working with local and international partners.

Here’s a link to and a citation for the paper,

Nanoengineered Sprayable Therapy for Treating Myocardial Infarction by Marcelo Muñoz, Cagla Eren Cimenci, Keshav Goel, Maxime Comtois-Bona, Mahir Hossain, Christopher McTiernan, Matias Zuñiga-Bustos, Alex Ross, Brenda Truong, Darryl R. Davis, Wenbin Liang, Benjamin Rotstein, Marc Ruel, Horacio Poblete, Erik J. Suuronen, and Emilio I. Alarcon. ACS Nano 2022, 16, 3, 3522–3537 DOI: https://doi.org/10.1021/acsnano.1c08890 Publication Date: February 14, 2022 Copyright © 2022 The Authors. Published by American Chemical Society

This paper appears to be open access.